Want to join the conversation?
Drug maker $BMY said that global sales for its blood thinning drug Eliquis more than doubled in 1Q16, and is on track to become the leading NOAC globally. The company said that its Hepatitis C portfolio also delivered strong performance with $427MM in revenues in 1Q16.
$AGIO plunge 15%.. what's happening... is this going for a toss !
Does anyone feel $SBUX CEO Schultz stepping down could prove a disaster for the company?
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.